Research Library

A new analysis reveals substantial global health gains for AIDS, malaria and neglected tropical diseases that were first targeted by the administration of President George W. Bush in 2003 and then greatly expanded by the Obama administration. Beginning in 2016, an incoming administration will have opportunities to build on this legacy to control and eliminate poverty-related diseases — including those with pandemic potential — and to assert American leadership while being mindful of fiscal constraints.

In this Baker Institute Viewpoints series, five experts on the marijuana industry examine the question, “What does the future hold for the cannabis industry, in Texas and beyond?”

In the current campaign for Harris County district attorney, both incumbent D.A. Devon Anderson and challenger Kim Ogg have not only proposed to change the way marijuana use is handled by that office, but have also made the issue a centerpiece of their campaigns. Drug policy fellow Katharine Neill examines each candidate’s proposed changes in a new Baker Institute Blog.

The human papillomavirus (HPV) affects over 80 million Americans, causing more than 40,000 cases of HPV-associated cancers in the U.S. In 2006, the FDA licensed the first HPV vaccine, which could help save thousands of lives; no cure for HPV currently exists. However, the political controversy raised by the vaccine has limited its acceptance and use. Such resistance potentially jeopardizes an opportunity to reduce cancer rates in Texas and the broader United States.

Stem cells from umbilical cord blood (CB) can be used to treat over 80 different diseases, including many types of leukemia, lymphoma and inherited immune system disorders. Extensive storage facilities in the United States and around the world collect, test and freeze CB for later use in medical procedures. However, the divide between two different banking models — public versus private — presents policy challenges. This policy report examines the difference between public and private cord blood banks and offers recommendations for US policymakers to improve cord blood banking and ensure high quality standards.